TIPS en pacientes cirróticos con trombosis venosa portal: una revisión de la literatura
DOI:
https://doi.org/10.59093/27112330.94Palabras clave:
derivación portosistémica intrahepática transyugular, hipertensión portal, trombosis, vena porta, cirrosis hepática.Resumen
En los últimos años, la trombosis de la vena porta entre los pacientes cirróticos se ha comportado como una entidad reconocida y cada vez más estudiada, no solo por su creciente incidencia, sino por la asociación con gravedad y mal pronóstico en cirrosis. Asimismo, se hacen objeto de estudio las terapias disponibles para el manejo tanto médico como quirúrgico de estos pacientes, lo que ha dado un papel importante a la derivación portosistémica transyugular intrahepática (TIPS). El uso de TIPS en esta población se posiciona como una alternativa de manejo aceptable, no solo por brindar mejoría en las complicaciones derivadas de la hipertensión portal, sino también por sus resultados prometedores en diferentes estudios sobre el flujo y la recanalización portal, y por su perfil de seguridad. Sin embargo, la eficacia, los efectos adversos a largo plazo y el pronóstico de dicha intervención en la compleja fisiopatología de la cirrosis deben continuar en estudio. El objetivo de este artículo es revisar los avances del uso de TIPS en el manejo de pacientes con cirrosis hepática y trombosis portal.
Descargas
Referencias bibliográficas
Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis 2015;19:199-221. https://doi.org/10.1016/j.cld.2014.09.012.
Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, et al. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med 2020;15:37-48. https://doi.org/10.1007/s11739-019-02252-8.
Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, et al. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-365. https://doi.org/10.1002/lt.24387.
Wang HL, Lu WJ, Zhang YL, Nie CH, Zhou TY, Zhou GH, et al. Comparison of transjugular intrahepatic portosystemic shunt in the treatment of cirrhosis with or without portal vein thrombosis: A retrospective study. Front Med (Lausanne) 2021;8:737984. https://doi.org/10.3389/fmed.2021.737984.
Lv Y, He C, Wang Z, Guo W, Wang J, Bai W, et al. Association of nonmalignant portal vein thrombosis and outcomes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. Radiology 2017;285:999-1010. https://doi.org/10.1148/radiol.2017162266.
Mancuso A. Management of portal vein thrombosis in cirrhosis: an update. Eur J Gastroenterol Hepatol 2016;28:739-743. https://doi.org/10.1097/meg.0000000000000633.
Jiang TT, Luo XP, Sun JM, Gao J. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World J Gastroenterol 2017;23:7470-7477. https://doi.org/10.3748/wjg.v23.i41.7470.
Ruiz-Blard E, Baiges A, Turon F, Hernández-Gea V, García-Pagán JC. [Early transjugular intrahepatic portosystemic shunt: When, how and in whom?]. Gastroenterol Hepatol 2016;39:472-476. https://doi.org/10.1016/j.gastrohep.2015.09.013.
Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, et al. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. World J Gastroenterol 2020;26:5561-5596. https://doi.org/10.3748/wjg.v26.i37.5561.
Dong F, Luo SH, Zheng LJ, Chu JG, Huang H, Zhang XQ, et al. Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency. World J Clin Cases 2019;7:2450-2462. https://doi.org/10.12998/wjcc.v7.i17.2450.
Rodríguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 2012;94:1145-1153. https://doi.org/10.1097/TP.0b013e31826e8e53.
Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147-156. https://doi.org/10.1056/NEJMra1011170.
Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW, et al. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci 2015;16:26087-26124. https://doi.org/10.3390/ijms161125942.
Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. J Hepatol 2013;59:265-270. https://doi.org/10.1016/j.jhep.2013.03.036.
Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 2011;9:1713-1723. https://doi.org/10.1111/j.1538-7836.2011.04429.x.
Sinegre T, Duron C, Lecompte T, Pereira B, Massoulier S, Lamblin G, et al. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis. J Thromb Haemost 2018;16:1132-1140. https://doi.org/10.1111/jth.14011.
Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 2021;75:442-453. https://doi.org/10.1016/j.jhep.2021.04.029.
Shalaby S, Simioni P, Campello E, Spiezia L, Gavasso S, Bizzaro D, et al. Endothelial damage of the portal vein is associated with heparin-like effect in advanced stages of cirrhosis. Thromb Haemost 2020;120:1173-1181. https://doi.org/10.1055/s-0040-1713169.
Anton A, Campreciós G, Pérez-Campuzano V, Orts L, García-Pagán JC, Hernández-Gea V. The pathophysiology of portal vein thrombosis in cirrhosis: Getting deeper into Virchow's triad. J Clin Med 2022;11:800. https://doi.org/10.3390/jcm11030800.
Stine JG, Wang J, Shah PM, Argo CK, Intagliata N, Uflacker A, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study. Liver Int 2018;38:94-101. https://doi.org/10.1111/liv.13500.
Strunk H, Marinova M. Transjugular intrahepatic portosystemic shunt (TIPS): Pathophysiologic basics, actual indications and results with review of the literature. Rofo 2018;190:701-711. https://doi.org/10.1055/a-0628-7347.
Lombardo S, Espejo JJ, Pérez-Montilla ME, Zurera LJ, González-Galilea Á. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiologia (Engl Ed) 2018;60:94-104. https://doi.org/10.1016/j.rx.2017.08.006.
Pécora RA, Canedo BF, Andraus W, Martino RB, Santos VR, Arantes RM, et al. Portal vein thrombosis in liver transplantation. Arq Bras Cir Dig 2012;25:273-278. https://doi.org/10.1590/s0102-67202012000400012.
Zhao M, Yue Z, Zhao H, Wang L, Fan Z, He F, et al. Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis. Sci Rep 2016;6:33069. https://doi.org/10.1038/srep33069.
de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022;76:959-974. https://doi.org/10.1016/j.jhep.2021.12.022.
Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015;64:1680-1704. https://doi.org/10.1136/gutjnl-2015-309262.
Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014-1048. https://doi.org/10.1002/hep.31884.
Zhang JB, Chen J, Zhou J, Wang XM, Chen S, Chu JG, et al. Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis. World J Clin Cases 2021;9:5179-5190. https://doi.org/10.12998/wjcc.v9.i19.5179.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016;64:179-202. https://doi.org/10.1016/j.jhep.2015.07.040.
Rugivarodom M, Charatcharoenwitthaya P. Nontumoral portal vein thrombosis: A challenging consequence of liver cirrhosis. J Clin Transl Hepatol 2020;8:432-444. https://doi.org/10.14218/jcth.2020.00067.
Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol 2014;31:235-242. https://doi.org/10.1055/s-0034-1382790.
Ferrusquía-Acosta J, Hernández-Gea V. TIPs indications and contraindications-Pushing the limits: Is earlier better? Curr Hepatol Rep 2019;18:87-95. https://doi.org/10.1007/s11901-019-00453-5.
García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. https://doi.org/10.1016/j.jhepr.2020.100122.
Yeoh SW, Kok HK. Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. J Dig Dis 2021;22:506-519. https://doi.org/10.1111/1751-2980.13035.
Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018;30:1187-1193. https://doi.org/10.1097/meg.0000000000001219.
Molvar C, Amin P. Portal vein thrombosis in cirrhosis: Interventional treatment options. Curr Gastroenterol Rep 2021;23:24. https://doi.org/10.1007/s11894-021-00826-1.
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology 2019;156:1582-1599.e1581. https://doi.org/10.1053/j.gastro.2019.01.265.
Senzolo M, Burra P, Patch D, Burroughs AK. Tips for portal vein thrombosis (PVT) in cirrhosis: not only unblocking a pipe. J Hepatol 2011;55:945-948. https://doi.org/10.1016/j.jhep.2011.02.027.
Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 2015;21:6769-6784. https://doi.org/10.3748/wjg.v21.i22.6769.
Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int 2012;6:576-590. https://doi.org/10.1007/s12072-011-9324-5.
Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Liver Int 2016;36:667-676. https://doi.org/10.1111/liv.12929.
Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, et al. Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: A prospective observational study. Am J Gastroenterol 2021;116:1447-1464. https://doi.org/10.14309/ajg.0000000000001194.
Senzolo M, T MS, Rossetto V, Burra P, Cillo U, Boccagni P, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012;32:919-927. https://doi.org/10.1111/j.1478-3231.2012.02785.x.
Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut 2018;67:2156-2168. https://doi.org/10.1136/gutjnl-2017-314634.
Thornburg B, Desai K, Hickey R, Hohlastos E, Kulik L, Ganger D, et al. Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: Final analysis of a 61-patient cohort. J Vasc Interv Radiol 2017;28:1714-1721.e1712. https://doi.org/10.1016/j.jvir.2017.08.005.
Li Z, Zhang W, Jiao DC, Zhou X, Zhou P, Si G, et al. Clinical study of transjugular intrahepatic portosystemic shunt combined with AngioJet thrombectomy for acute portal vein thrombosis in non-cirrhosis. Medicine (Baltimore) 2021;100:e24465. https://doi.org/10.1097/md.0000000000024465.
Wan YM, Li YH, Wu HM, Xu ZY, Xu Y, Yang LH, et al. Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant). Medicine (Baltimore) 2017;96:e8498. https://doi.org/10.1097/md.0000000000008498.
Zhan C, Prabhu V, Kang SK, Li C, Zhu Y, Kim S, et al. Comparison of non-tumoral portal vein thrombosis management in cirrhotic patients: TIPS versus anticoagulation versus no treatment. J Clin Med 2021;10:2316. https://doi.org/10.3390/jcm10112316.
Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. https://doi.org/10.1016/j.jhepr.2021.100316.
Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crinò F, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 2012;265:124-132. https://doi.org/10.1148/radiol.12112236.
Barbier CE, Rorsman F, Eriksson LG, Sangfelt P, Sheikhi R, Vessby J, et al. Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions-A retrospective evaluation. Acta Radiol Open 2020;9:2058460120964074. https://doi.org/10.1177/2058460120964074.
Klinger C, Riecken B, Schmidt A, De Gottardi A, Meier B, Bosch J, et al. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Dig Liver Dis 2017;49:1345-1352. https://doi.org/10.1016/j.dld.2017.05.020.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Hepatología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
La política de reconocimiento de autoría de Hepatología se basa en los criterios indicados por el ICMJE para conferir crédito de un trabajo a una persona, a la vez que se le atribuye responsabilidad por la publicación del mismo.
